ArticleWorld journal of transplantation2025
Endocrine-related neurological function recovery in pancreatic transplantation.
Article in World journal of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPancreas transplantation (PT) has emerged as a critical therapeutic intervention for patients with type 1 diabetes mellitus (T1DM). This procedure restores neuroendocrine communication, which is essential for optimal pancreatic function and insulin regulation. The recovery process involves multiple phases, including neural regeneration, revascularization, and the re-establishment of synaptic connections, all of which contribute to the restoration of both endocrine and neurological functions.
aimTo systematically examine the mechanisms underlying neurological recovery following PT, to explore the role of endocrine factors in restoring neurofunctional integrity, and to evaluate the impact of immunosuppressive therapy on nerve regeneration and its clinical outcomes.
methodsA comprehensive literature search was conducted across international databases such as PubMed, Web of Science, and Cochrane Library to identify studies addressing PT, neurological recovery, and endocrine regulation. Inclusion criteria encompassed randomized controlled trials, cohort studies, and systematic reviews. The review focused on the neurogenic mechanisms activated post-transplantation, the effect of glycemic control on nerve repair, and the implications of immunosuppressive drugs on the process of neurological recovery.
resultsA total of 211 articles were initially identified through the literature search across international databases such as PubMed, Web of Science, and Cochrane Library. Following a detailed evaluation and the application of inclusion and exclusion criteria, 56 articles were further reviewed, and 8 were selected for the final analysis. Additionally, a comprehensive patent search yielded 168 patents, out of which 6 were selected for further examination. These sources, including both journal literature and patents, offer significant insights into the mechanisms of neurological recovery and endocrine function following PT, with an emphasis on nerve regeneration, glycemic control, and the impact of immunosuppressive therapy.
conclusionPT represents a promising intervention for restoring both endocrine and neurological functions in patients with T1DM. Glycemic control, neural regeneration, and the restoration of neuroendocrine signaling are key components of successful recovery. While the procedure yields substantial improvements in nerve function, challenges persist, particularly in patients with long-standing diabetes or severe neuropathy. The dual impact of immunosuppressive drugs on immune suppression and neurotoxicity necessitates careful management. Future research should focus on refining immunosuppressive protocols and exploring advanced therapeutic options, including stem cell-based interventions, to enhance neural regeneration and further improve clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.